Bristol-Myers Squibb buy The Goldman Sachs Group, Inc.
Start price
30.10.23
/
50%
€48.25
Target price
30.10.24
€65.03
Performance (%)
-6.99%
Price
26.08.24
€43.23
Summary
This prediction is currently active. With a performance of -6.99%, the BUY prediction for Bristol-Myers Squibb by The_Goldman_Sachs_Gr is down slightly. A total of €1.65 was paid as dividends for this prediction. This prediction currently runs until 30.10.24. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Bristol-Myers Squibb | -2.811% | -2.811% |
iShares Core DAX® | 1.056% | 1.056% |
iShares Nasdaq 100 | -1.886% | -0.160% |
iShares Nikkei 225® | 2.553% | 4.359% |
iShares S&P 500 | -0.434% | 0.224% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $81.00 to $69.00. They now have a "buy" rating on the stock.
Ratings data for BMY provided by MarketBeat